- Home
- SRM vs PMCB Comparison
SRM vs PMCB Comparison
Compare SRM & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- PMCB
- Stock Information
- Founded
- SRM 1979
- PMCB 1996
- Country
- SRM United States
- PMCB United States
- Employees
- SRM N/A
- PMCB N/A
- Industry
- SRM
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRM
- PMCB Health Care
- Exchange
- SRM Nasdaq
- PMCB Nasdaq
- Market Cap
- SRM 9.0M
- PMCB 7.3M
- IPO Year
- SRM 2023
- PMCB N/A
- Fundamental
- Price
- SRM $7.93
- PMCB $1.11
- Analyst Decision
- SRM
- PMCB
- Analyst Count
- SRM 0
- PMCB 0
- Target Price
- SRM N/A
- PMCB N/A
- AVG Volume (30 Days)
- SRM 20.8M
- PMCB 11.8K
- Earning Date
- SRM 08-11-2025
- PMCB 08-12-2025
- Dividend Yield
- SRM N/A
- PMCB N/A
- EPS Growth
- SRM N/A
- PMCB N/A
- EPS
- SRM N/A
- PMCB 1.29
- Revenue
- SRM $4,394,659.00
- PMCB N/A
- Revenue This Year
- SRM N/A
- PMCB N/A
- Revenue Next Year
- SRM N/A
- PMCB N/A
- P/E Ratio
- SRM N/A
- PMCB $0.88
- Revenue Growth
- SRM N/A
- PMCB N/A
- 52 Week Low
- SRM $0.26
- PMCB $1.00
- 52 Week High
- SRM $12.80
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- SRM 61.58
- PMCB 54.71
- Support Level
- SRM $6.42
- PMCB $1.00
- Resistance Level
- SRM $8.85
- PMCB $1.07
- Average True Range (ATR)
- SRM 2.02
- PMCB 0.05
- MACD
- SRM -0.11
- PMCB 0.01
- Stochastic Oscillator
- SRM 54.11
- PMCB 73.33
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.